Simulation of Protein Dynamics for Mechanistic Insight and Drug Design

Simulation of Protein Dynamics for Mechanistic Insight and Drug Design

Simulation of protein dynamics for mechanistic insight and drug design A thesis submitted to The University of Manchester for the degree of Master of Philosophy in the Faculty of Biology, Medicine and Health 2019 YANG, Zhang School of Health Sciences/Division of Pharmacy List of contents List of figures ............................................................................................................................ 5 List of tables ........................................................................................................................... 14 List of abbreviations ............................................................................................................... 16 Abstract .................................................................................................................................. 18 Declaration ............................................................................................................................. 20 Copyright Statement .............................................................................................................. 21 Acknowledgements ................................................................................................................ 22 Introduction to protein dynamics in drug design .................................................................. 23 In silico design of anti-cancer compounds targeting R-spondin using molecular dynamics and free energy calculations .................................................................................................. 24 1. Background ........................................................................................................................ 24 1.1 Wnt signalling pathway ............................................................................................ 24 1.2 R-spondin signalling and disease ............................................................................. 26 1.3 Structure basis of R-spondin signalling .................................................................... 29 1.4 Protein dynamics...................................................................................................... 31 1.5 Aim of this work ....................................................................................................... 33 2. Computational Theory ...................................................................................................... 35 2.1 Protein-ligand binding site prediction ..................................................................... 35 2.1.1 Shape-based methodology ............................................................................... 36 2.1.2 Energy-based methodology .............................................................................. 37 2.2 Molecular docking .................................................................................................... 38 2.2.1 Molecular docking algorithms .......................................................................... 39 2.2.2 Scoring functions ............................................................................................... 41 2.3 Molecular dynamics ................................................................................................. 43 2.3.1 Molecular mechanics ........................................................................................ 43 2.3.2 Water solvent models ....................................................................................... 45 2.3.3 Periodical boundary conditions ........................................................................ 46 2.3.4 Temperature and pressure regulation .............................................................. 47 2.4 Free energy calculation ............................................................................................ 48 2.4.1 Poisson Boltzmann potential ............................................................................ 48 2.4.2 Generalized Born model ................................................................................... 49 2.4.3 MM-GBSA method ............................................................................................ 50 3. High throughput virtual screening .................................................................................... 51 2 3.1 Compound database refinement ............................................................................. 53 3.2 Binding pocket identification ................................................................................... 55 3.2.1 Closed and Open2 R-spondin binding pockets ................................................. 55 3.2.2 RNF43 binding pockets ..................................................................................... 61 3.2.3 LGR5 binding pockets ........................................................................................ 63 3.3 Molecular docking and protein-ligand interactions ................................................. 66 3.3.1 Methods ............................................................................................................ 66 3.3.2 Closed R-spondin interactions .......................................................................... 67 3.3.3 Open2 R-spondin interactions .......................................................................... 70 3.3.4 RNF43 interactions ............................................................................................ 72 3.3.5 LGR5 interactions .............................................................................................. 76 4 Molecular dynamics simulation ......................................................................................... 79 4.1 Methods ................................................................................................................... 80 4.1.1 Model construction ........................................................................................... 80 4.1.2 Molecular dynamics protocol ........................................................................... 81 4.1.3 Compounds selection and optimization ........................................................... 81 4.1.4 Analysis tools..................................................................................................... 82 4.2 Results: Closed R-spondin ligands ............................................................................ 83 4.2.1 Compound selection ......................................................................................... 83 4.2.2 Ligand Binding stabilities................................................................................... 90 4.2.3 Ligand structure refinement ............................................................................. 94 4.2.4 Special cases .................................................................................................... 100 4.3 Results: Open2 R-spondin ligands .......................................................................... 105 4.3.1 Compound selection ....................................................................................... 105 4.3.2 Ligand Binding stabilities................................................................................. 110 4.3.3 Ligand structure refinement ........................................................................... 113 4.3.4 Special cases .................................................................................................... 118 4.4 Results: RNF43 ligands ........................................................................................... 123 4.4.1 Compound selection ....................................................................................... 123 4.4.2 Ligand Binding stabilities................................................................................. 128 4.4.3 Ligand structure refinement ........................................................................... 137 4.5 Results: LGR5 ligands ............................................................................................. 141 4.5.1 Compound selection ....................................................................................... 141 4.5.2 Ligand Binding stabilities................................................................................. 143 4.5.3 Ligand structure refinement ........................................................................... 149 4.5.4 Special cases .................................................................................................... 155 3 5. Free energy calculation ................................................................................................... 157 5.1 Methods ................................................................................................................. 157 5.2 Binding free energy and energy decomposition .................................................... 159 5.2.1 Closed R-spondin ............................................................................................ 159 5.2.2 Open2 R-spondin ............................................................................................ 162 5.2.3 RNF43 .............................................................................................................. 169 5.2.4 LGR5 ................................................................................................................ 173 6. Discussion .......................................................................................................................

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    188 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us